0W8N Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
0W8N FAQ
What was Nexstim PLC’s price range in the past 12 months?
Currently, no data Available
What is Nexstim PLC’s market cap?
Nexstim PLC’s market cap is €76.63M.
When is Nexstim PLC’s upcoming earnings report date?
Nexstim PLC’s upcoming earnings report date is Mar 01, 2027 which is in 194 days.
How were Nexstim PLC’s earnings last quarter?
Nexstim PLC released its earnings results on Aug 14, 2026. The company reported -€0.12 earnings per share for the quarter, missing the consensus estimate of -€0.05 by -€0.07.
Is Nexstim PLC overvalued?
According to Wall Street analysts Nexstim PLC’s price is currently same.
Does Nexstim PLC pay dividends?
Nexstim PLC does not currently pay dividends.
What is Nexstim PLC’s EPS estimate?
Nexstim PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Nexstim PLC have?
Nexstim PLC has 8,074,859 shares outstanding.
What happened to Nexstim PLC’s price movement after its last earnings report?
Nexstim PLC reported an EPS of -€0.12 in its last earnings report, missing expectations of -€0.05. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Nexstim PLC?
Currently, no hedge funds are holding shares in GB:0W8N
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Nexstim PLC
Nexstim Plc, a medical technology enterprise, specializes in the creation and global distribution of non-invasive brain stimulation technologies, with operations spanning Finland, Europe, North America, and other international markets. Central to its offerings is the proprietary SmartFocus technology, featuring 3D navigation, which underpins its navigated transcranial magnetic stimulation (TMS) approach utilized for both therapeutic interventions and diagnostic assessments. The company provides two distinct systems: the NBT system, a navigated brain therapy solution designed for addressing major depression and chronic neuropathic pain, and the NBS system, a navigated brain stimulation device engineered for precise pre-surgical mapping of the brain's speech and motor cortices. Nexstim predominantly sells its NBS systems to academic institutions and teaching hospitals. Established in 2000, Nexstim Plc's corporate headquarters are located in Helsinki, Finland.